Offc Action Outgoing

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

 

 

NONFINAL OFFICE ACTION

 

The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned.  Respond using the Trademark Electronic Application System (TEAS).  A link to the appropriate TEAS response form appears at the end of this Office action. 

 

 

Issue date:  September 02, 2020

 

 

SEARCH OF USPTO DATABASE OF MARKS

 

The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d).  15 U.S.C. §1052(d); TMEP §704.02.

 

The referenced application has been reviewed by the assigned trademark examining attorney.  Applicant must respond timely and completely to the issue(s) below.  15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.

 

SUMMARY OF ISSUES:

• Requirement for an Acceptable Identification of Goods
• Requirement for Information

 

IDENTIFICATION OF GOODS

 

Applicant’s mark includes the wording “COVID”, which indicates that applicant’s goods are related to COVID-19. According to Dictionary.com, COVID-19, (Coronavirus Disease 2019), a disease that was declared a global pandemic, can also be referred to by the shorted form COVID. See http://www.dictionary.com/browse/covid-19. Further, the attached evidence shows that the phrase COVID is used as an abbreviation of COVID-19:

 

•           The White House http://www.whitehouse.gov/openingamerica/ (released guidelines for re-opening businesses and stated “State and local officials may need to tailor the application of these criteria to local circumstances (e.g., metropolitan areas that have suffered severe COVID outbreaks, rural and suburban areas where outbreaks have not occurred or have been mild).”)

•           The U.S. Department of Health & Human Services http://www.acf.hhs.gov/cb/events/cw-worker-safety-time-covid (offered a “Child Welfare Worker Safety in the Time of COVID” webinar.)

•           The New York Times http://www.nytimes.com/2020/06/26/opinion/coronavirus-brain-damage-dementia.html (article titled “Can Covid Damage the Brain?”)

 

The relationship of applicant’s goods to the COVID-19 pandemic is likely to affect the purchasing decision of a significant portion of relevant consumers because the ability of the goods to treat COVID-19 is highly desirable for consumers. However, if some or all of the goods will not in fact have or exhibit this feature or characteristic, then registration may be refused because the mark consists of or includes deceptive matter in relation to the identified goods.   See 15 U.S.C. §1052(a); In re Budge Mfg. Co., 857 F.2d 773, 8 USPQ2d 1259 (Fed. Cir. 1988); TMEP §1203.02-.02(b).

 

To avoid such refusal, applicant may amend the identification to specify that the goods possess this relevant feature or characteristic.  See TMEP §§1203.02(e)(ii), (f)(i), 1402.05 et seq.  However, merely amending the identification to exclude goods with the named feature or characteristic will not avoid a deceptiveness refusal.  TMEP §1203.02(f)(i).

 

Therefore, applicant may amend the identification to the following, if accurate: 

 

“Fusion protein pharmaceutical preparations for the treatment or prevention of infectious diseases, namely, COVID-19 and Coronavirus; Pharmaceutical preparations for the treatment of COVID-19/Coronavirus” in Class 005

 

Applicant may amend the identification to clarify or limit the goods, but not to broaden or expand the goods beyond those in the original application or as acceptably amended.  See 37 C.F.R. §2.71(a); TMEP §1402.06.  Generally, any deleted goods may not later be reinserted.  See TMEP §1402.07(e).

 

Specimen of Use Advisory: As SARS-CoV-2 is a novel coronavirus and COVID-19 has never been seen in humans before late 2019, goods or services related to coronavirus transmission and the treatment of COVID-19 are in early stages of development. See http://www.fda.gov/consumers/consumer-updates/beware-fraudulent-coronavirus-tests-vaccines-andtreatments. Upon consideration of an allegation of use, if the specimen of use shows the applied-for mark used with goods that make unproven claims regarding coronaviruses and COVID-19, registration may be refused on the basis the applied-for mark includes deceptive matter.

INFORMATION ABOUT GOODS REQUIRED

 

The nature of the goods with which applicant intends to use or is using the mark is not clear from the present record and additional information is required.  To permit proper examination of the application, applicant must provide the following:

 

(1)        A written statement explaining whether all of the goods will treat COVID-19.

 

(2)        A written statement describing in detail the nature, purpose, and channels of trade of the goods.

 

See 37 C.F.R. §2.61(b); TMEP §§814, 1402.01(e). 

 

Failure to comply with a request for information is grounds for refusing registration.  In re Harley, 119 USPQ2d 1755, 1757-58 (TTAB 2016); TMEP §814.  Merely stating that information about the goods or services is available on applicant’s website is an insufficient response and will not make the relevant website information of record.  See In re Planalytics, Inc., 70 USPQ2d 1453, 1457-58 (TTAB 2004).

 

Applicant is advised that, if applicant’s response to the request for information indicates that the goods identified in the application do not or will not treat COVID-19 registration may be refused on the ground that the applied-for mark is deceptive.  Trademark Act Section 2(a), 15 U.S.C. §1052(a); see In re Budge Mfg. Co., 857 F.2d 773, 775-77, 8 USPQ2d 1259, 1260-62 (Fed. Cir. 1988); In re ALP of S. Beach Inc., 79 USPQ2d 1009, 1010 (TTAB 2006); TMEP §1203.02-.02(e).  Registration may also be refused, in the alternative, on the ground that the applied-for mark is deceptively misdescriptive.  15 U.S.C. §1052(e)(1); see In re Berman Bros. Harlem Furniture Inc., 26 USPQ2d 1514, 1515-16 (TTAB 1993); TMEP §§1203.02(e), 1209.04.

 

RESPONSE ADVISORIES

 

Please email the assigned trademark examining attorney with questions about this Office action.  Although an examining attorney cannot provide legal advice, the examining attorney can provide additional explanation about the issues in this Office action.  See TMEP §§705.02, 709.06. 

 

The USPTO does not accept emails as responses to Office actions; however, emails can be used for informal communications and are included in the application record.  See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05. 

 

How to respond.  Click to file a response to this nonfinal Office action.    

 

 

/Ms. Tasneem Hussain/

Trademark Examining Attorney

Law Office 130

tasneem.hussain@uspto.gov (preferred)

571.272.8273

 

 

RESPONSE GUIDANCE

• Missing the response deadline to this letter will cause the application to abandon.  A response or notice of appeal must be received by the USPTO before midnight Eastern Time of the last day of the response period.  TEAS and ESTTA maintenance or unforeseen circumstances could affect an applicant’s ability to timely respond.  

 

• Responses signed by an unauthorized party are not accepted and can cause the application to abandon.  If applicant does not have an attorney, the response must be signed by the individual applicant, all joint applicants, or someone with legal authority to bind a juristic applicant.  If applicant has an attorney, the response must be signed by the attorney.

 

• If needed, find contact information for the supervisor of the office or unit listed in the signature block.

 

United States Patent and Trademark Office (USPTO)

 

USPTO OFFICIAL NOTICE

 

Office Action (Official Letter) has issued

on September 02, 2020 for

U.S. Trademark Application Serial No. 88846389

 

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter that you must respond to by the specified deadline or your application will be abandoned.  Please follow the steps below.

 

(1)  Read the official letter.

 

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

 

 

/Ms. Tasneem Hussain/

Trademark Examining Attorney

Law Office 130

tasneem.hussain@uspto.gov (preferred)

571.272.8273

 

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

 

(3)  Respond within 6 months (or earlier, if required in the Office action) from September 02, 2020, using the Trademark Electronic Application System (TEAS).  The response must be received by the USPTO before midnight Eastern Time of the last day of the response period.  See the Office action for more information about how to respond

 

 

 

GENERAL GUIDANCE

·         Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

 

·         Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

 

·         Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”